Unknown NA INTERVENTIONAL 2-arm NCT00893594

Efficacy of Sumatriptan With Naprosyn in Migraine With Aura

A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura

Sponsor: Dent Neurologic Institute

Conditions Migraine With Aura

Interventions placebo sumatriptan with naprosyn

Updated 6 times since 2017 Last updated: Feb 18, 2015 Started: Oct 31, 2010 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00893594, this NA trial focuses on Migraine With Aura and remains ongoing. Sponsored by Dent Neurologic Institute, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dent Neurologic Institute

Data source: Dent Neurologic Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amherst, United States